Edgewise IPO, Inscripta round leads Colorado bioscience’s largest venture funding quarter on record

DENVER — The Colorado Bioscience Association said the state’s biotech industry set a record for new venture funding in the first quarter of 2021, with a lion’s share of those dollars coming from Boulder-area companies.

The trade association said Tuesday that biotech companies in the state raised $704 million in the last quarter. That figure is more than half of the $1.2 billion in venture funding issued in the entirety of 2020 and well on its way toward eclipsing the $850 million or so issued in 2019.

Those annual figures do not include Pfizer Inc. (NYSE: PFE) acquiring Array Biopharma for $11.4…